May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Posterior Sub–Tenonís Triamcinolone Acetonide for Refractory Diabetic Macular Edema.
Author Affiliations & Notes
  • T. Yoshinaga
    Department of Ophthalmology and Visual Science, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
  • Y. Mawatari
    Department of Ophthalmology and Visual Science, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
  • J. Inumaru
    Department of Ophthalmology and Visual Science, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
  • M. Fukushima
    Department of Ophthalmology and Visual Science, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
  • H. Tanihara
    Department of Ophthalmology and Visual Science, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
  • Footnotes
    Commercial Relationships  T. Yoshinaga, None; Y. Mawatari, None; J. Inumaru, None; M. Fukushima, None; H. Tanihara, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4104. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Yoshinaga, Y. Mawatari, J. Inumaru, M. Fukushima, H. Tanihara; Posterior Sub–Tenonís Triamcinolone Acetonide for Refractory Diabetic Macular Edema. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4104.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To study the effect of sub–Tenonís triamcinolone acetonide (TA) as a treatment for refractory diabetic macular edema (DME). Method: Prospective monocentric pilot study of patients who had received a posterior sub–Tenonís injection of 40mg TA as a treatment of DME. 18 eyes of 17 patients (10 women and 7 men, aged 38 – 73 years) were treated. In all eyes, panretinal photocoaguration and focal photocoagulation for DME had been performed. 11 eyes had undergone vitrectomy (5 eyes for proliferative diabetic retinopathy, 6 eyes for DME). All eyes were examined before and throughout follow–up with visual acuity, anterior chamber laser flare cell meter, fluorescein angiography (FA), and optical coherence topography (OCT). Results: Mean follow–up time was 4.1 months (range 3– 5months). In 13 eyes (72.2 %), central retinal thickness had reduced significantly as measured by OCT. At the same time, the breakdown of blood–ocular barrier was improved as observed laser flare cell meter and FA . However the edema recurred in 5 eyes (27.8%), 2 to 4 months after TA injection. Visual acuity improved in 4 eyes (22.2%), remained in 14 eyes (77.8%), and reduced in no eyes. Intraocular pressure elevation more than 21 mmHg was observed transiently in one eye (5.6%). No other complications were not observed. Conclusion: Posterior sub–Tenonís injection of TA may be useful for improvement of diabetic macular edema, however the recurrence sometimes occur.

Keywords: diabetic retinopathy • macula/fovea • corticosteroids 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×